EIF4E
Gene Ontology Biological Process
- G1/S transition of mitotic cell cycle [IMP]
- RNA metabolic process [TAS]
- cellular protein metabolic process [TAS]
- cytokine-mediated signaling pathway [TAS]
- gene expression [TAS]
- insulin receptor signaling pathway [TAS]
- mRNA export from nucleus [TAS]
- mRNA metabolic process [TAS]
- nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [TAS]
- nuclear-transcribed mRNA poly(A) tail shortening [TAS]
- positive regulation of mitotic cell cycle [IMP]
- regulation of translation [IDA]
- translation [TAS]
- translational initiation [TAS]
Gene Ontology Molecular Function
Gene Ontology Cellular Component
PRPF19
Gene Ontology Biological Process
- cellular protein localization [IMP]
- double-strand break repair via nonhomologous end joining [IMP]
- generation of catalytic spliceosome for first transesterification step [IBA]
- mRNA splicing, via spliceosome [IC, IDA]
- proteasomal protein catabolic process [IMP]
- protein K63-linked ubiquitination [IMP]
- protein polyubiquitination [IDA]
- signal transduction involved in DNA damage checkpoint [IMP]
- spliceosomal complex assembly [IMP]
- spliceosomal tri-snRNP complex assembly [IDA]
Gene Ontology Molecular Function
Gene Ontology Cellular Component
Affinity Capture-Western
An interaction is inferred when a bait protein is affinity captured from cell extracts by either polyclonal antibody or epitope tag and the associated interaction partner identified by Western blot with a specific polyclonal antibody or second epitope tag. This category is also used if an interacting protein is visualized directly by dye stain or radioactivity. Note that this differs from any co-purification experiment involving affinity capture in that the co-purification experiment involves at least one extra purification step to get rid of potential contaminating proteins.
Publication
The eukaryotic translation initiation factor eIF4E reprograms alternative splicing.
Aberrant splicing is typically attributed to splice-factor (SF) mutation and contributes to malignancies including acute myeloid leukemia (AML). Here, we discovered a mutation-independent means to extensively reprogram alternative splicing (AS). We showed that the dysregulated expression of eukaryotic translation initiation factor eIF4E elevated selective splice-factor production, thereby impacting multiple spliceosome complexes, including factors mutated in AML such as SF3B1 and ... [more]
Throughput
- Low Throughput
Curated By
- BioGRID